EnvisionRheumat Profile picture
πŸ“·Snapshots of #Rheumatology Visual Abstracts One stop destination to everything HOTπŸ”₯(How to treat) & WIN(What'sπŸ†•οΈ)in Rheumat #Rheumtwitter By: @kunalchandwar

Nov 12, 2022, 5 tweets

#ACR2022 #ACR22
12S102. Year in Review πŸ‘ŒπŸ»
1st to be discussed was the Gloria Trial
Glucocorticoids effective but safety an issue

#ACR2022 #ACR22
12S102. Year in Review πŸ‘ŒπŸ»
Next to the most discussed study of the year
Oral surveillance trial
The CV risk is higher in those with ASCVD - NNH 16😳

#ACR2022 #ACR22
12S102. Year in Review πŸ‘ŒπŸ»
Next to the Proderm Study
Cost, thromboembolism a concern in the first positive phase 3 RCT in myositis

#ACR2022 #ACR22
12S102. Year in Review πŸ‘ŒπŸ»
it was an exciting year for lupus research
from CAR-T to BDCA2, B-cell and Iberdomide

#ACR2022 #ACR22
12S102. Year in Review πŸ‘ŒπŸ»
IV Tocilizumab approved for GCA
and shows GC sparing

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling